In Vivo
The blockbuster business model that underpinned Big Pharma's success is now irreparably broken. The industry needs a new approach.
First published in Νοέμβριος 2003
The blockbuster business model that underpinned Big Pharma's success is now irreparably broken. The industry needs a new approach.